Caldwell Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-213
| Closed | -$8.18K | – | 758 |
|
|
2025
Q2 | $8.18K | Sell |
213
-24,420
| -99% | -$933K | ﹤0.01% | 650 |
|
|
2025
Q1 | $954K | Sell |
24,633
-863
| -3% | -$31.6K | 0.1% | 165 |
|
|
2024
Q4 | $862K | Hold |
25,496
| – | – | 0.09% | 174 |
|
|
2024
Q3 | $1.04M | Sell |
25,496
-314
| -1% | -$12.8K | 0.11% | 153 |
|
|
2024
Q2 | $994K | Buy |
25,810
+439
| +2% | +$18.5K | 0.11% | 149 |
|
|
2024
Q1 | $1.09M | Buy |
25,371
+24,435
| +2,611% | +$1.01M | 0.13% | 140 |
|
|
2023
Q4 | $34.7K | Hold |
936
| – | – | ﹤0.01% | 489 |
|
|
2023
Q3 | $33.9K | Sell |
936
-641
| -41% | -$22.8K | ﹤0.01% | 485 |
|
|
2023
Q2 | $56.2K | Buy |
1,577
+56
| +4% | +$2.01K | 0.01% | 431 |
|
|
2023
Q1 | $54.1K | Sell |
1,521
-200
| -12% | -$7K | 0.01% | 426 |
|
|
2022
Q4 | $60.5K | Sell |
1,721
-364
| -17% | -$12.1K | 0.01% | 395 |
|
|
2022
Q3 | $61.4K | Sell |
2,085
-1
| -0% | -$38 | 0.01% | 402 |
|
|
2022
Q2 | $113K | Sell |
2,086
-200
| -9% | -$11K | 0.02% | 347 |
|
|
2022
Q1 | $124K | Sell |
2,286
-48
| -2% | -$2.61K | 0.01% | 343 |
|
|
2021
Q4 | $129K | Buy |
2,334
+364
| +18% | +$18.9K | 0.01% | 340 |
|
|
2021
Q3 | $94.1K | Buy |
1,970
+400
| +25% | +$20.1K | 0.01% | 369 |
|
|
2021
Q2 | $78.1K | Sell |
1,570
-332
| -17% | -$16K | 0.01% | 391 |
|
|
2021
Q1 | $84.8K | Buy |
1,902
+364
| +24% | +$16.5K | 0.01% | 369 |
|
|
2020
Q4 | $70.7K | Buy |
1,538
+98
| +7% | +$4.5K | 0.01% | 375 |
|
|
2020
Q3 | $67.8K | Hold |
1,440
| – | – | 0.01% | 377 |
|
|
2020
Q2 | $73.4K | Hold |
1,440
| – | – | 0.01% | 373 |
|
|
2020
Q1 | $68.2K | Hold |
1,440
| – | – | 0.01% | 374 |
|
|
2019
Q4 | $84.6K | Buy |
+1,440
| New | +$80.1K | 0.01% | 392 |
|
Other funds holding GSK
JEST
